480 related articles for article (PubMed ID: 25936305)
1. Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.
Artemeva NV; Safarova MS; Ezhov MV; Afanasieva OI; Dmitrieva OA; Pokrovsky SN
Atheroscler Suppl; 2015 May; 18():53-8. PubMed ID: 25936305
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
Afanasieva OI; Ezhov MV; Razova OA; Afanasieva MI; Utkina EA; Pokrovsky SN
Atherosclerosis; 2018 Oct; 277():477-482. PubMed ID: 30270088
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
[TBL] [Abstract][Full Text] [Related]
4. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
Roeseler E; Julius U; Heigl F; Spitthoever R; Heutling D; Breitenberger P; Leebmann J; Lehmacher W; Kamstrup PR; Nordestgaard BG; Maerz W; Noureen A; Schmidt K; Kronenberg F; Heibges A; Klingel R;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2019-27. PubMed ID: 27417585
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein (a): perspectives from a lipid-referral program.
Rubenfire M; Vodnala D; Krishnan SM; Bard RL; Jackson EA; Giacherio D; Brook RD
J Clin Lipidol; 2012; 6(1):66-73. PubMed ID: 22264576
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
[TBL] [Abstract][Full Text] [Related]
8. [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels].
Safarova MS; Trukhacheva EP; Ezhov MV; Afanas'eva OI; Afanas'eva MI; Tripoten' MI; Liakishev AA; Pokrovskiĭ SN
Kardiologiia; 2011; 51(5):9-16. PubMed ID: 21649590
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) and coronary heart disease.
Rodriguez CR; Seman LJ; Ordovas JM; Jenner J; Genest MS; Wilson PW; Schaefer EJ
Chem Phys Lipids; 1994 Jan; 67-68():389-98. PubMed ID: 8187239
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
[TBL] [Abstract][Full Text] [Related]
11. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study.
Sharma M; Sharma DR; Singh V; Panwar RB; Hira HS; Mohan B; Kumar N; Sharma SK; Gupta R
Vasc Health Risk Manag; 2006; 2(1):87-93. PubMed ID: 17319473
[TBL] [Abstract][Full Text] [Related]
13. Practical management of dyslipidemia with elevated lipoprotein(a).
Riche DM; East HE; Priest HM
J Am Pharm Assoc (2003); 2008; 48(6):803-7. PubMed ID: 19019811
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
[TBL] [Abstract][Full Text] [Related]
15. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
[TBL] [Abstract][Full Text] [Related]
16. Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a).
Vavlukis M; Mladenovska K; Daka A; Dimovski A; Domazetovska S; Kuzmanovska S; Kedev S
Ann Pharmacother; 2016 Aug; 50(8):609-15. PubMed ID: 27242350
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a)-clinical aspects and future challenges.
Kurt B; Soufi M; Sattler A; Schaefer JR
Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):26-32. PubMed ID: 25732622
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a) and apolipoprotein (a) phenotypes in healthy Macedonian children.
Tosheska K; Labudovic D; Alabakovska S; Handziski Z; Spiroski M; Todorova B
Bratisl Lek Listy; 2007; 108(4-5):179-83. PubMed ID: 17694801
[TBL] [Abstract][Full Text] [Related]
19. Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype.
Yahya R; Berk K; Verhoeven A; Bos S; van der Zee L; Touw J; Erhart G; Kronenberg F; Timman R; Sijbrands E; Roeters van Lennep J; Mulder M
Atherosclerosis; 2019 Oct; 289():201-205. PubMed ID: 31327478
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
